$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business

2021 Startups to Watch
stats here
Related Posts on Startland News
Culture Lab to Fountain City Fintech startups: Before you hire, define your culture
Bringing Culture Lab programming to the Fountain City Fintech accelerator’s inaugural cohort is part of a deeper effort to call attention to workplace culture in Kansas City, said Frank Keck. “We’ve been able to help each of these six cohort companies really define who they are, why are they doing what they’re doing, and help…
Investors deal BacklotCars $8M; KC-based startup hitting the gas on disruption
Disrupting the used car space has driven a Series A funding round to $8 million for Kansas City-based startup BacklotCars, the company announced Tuesday. “This investment comes at a great time. We are growing rapidly in our existing markets and expanding our national footprint. We expect to continue to add new features – to accompany…
Passive investment approach is so 30 years ago, Drawbridge strategist says
Transforming a systematic process into a company built on efficiency has Lee’s Summit-based Drawbridge Strategies ready to disrupt the world of finance, said Tim Fortier. “A product is a means to an end, not the end itself. What is necessary is better investor education on the process behind the product,” said Fortier, Drawbridge Strategies CIO.…
ebbie navigates journey from established insurance industry to tech startup mode
Olathe-based ebbie is injecting innovation into the risk-averse insurance industry, said Brian Hess. “We looked for spaces where we could come in and say, ‘We can make this a lot better,’” said Hess, operations officer at ebbie. “Fast forward to now, and we went through the development phase and the build, and we have successfully…

